|
End-of-day quote
Bulgaria S.E.
27/10/2026
|
5-day change | 1st Jan Change | ||
| 3.270 EUR | -0.61% |
|
+7.57% | +129.54% |
| 09-21 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 08-28 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.27B 1.96B 1.76B 1.63B 1.47B 2.76B 186B 2.79B 19.49B 7.74B 97.67B 7.36B 7.21B 310B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 3.81B 2.29B 2.05B 1.9B 1.72B 3.21B 217B 3.25B 22.72B 9.02B 114B 8.58B 8.4B 361B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | -0.61% | ||
| 1 week | +7.57% | ||
| Current month | +26.25% | ||
| 1 month | +26.74% | ||
| 3 months | +72.11% | ||
| 6 months | +89.02% | ||
| Current year | +129.54% |
| 1 week | 3.08 |  | 3.37 |
| 1 month | 2.49 | | 3.37 |
| Current year | 1.41 | | 3.37 |
| 1 year | 1.34 | | 3.37 |
| 3 years | 0.94 | | 3.37 |
| 5 years | 0.68 | | 3.37 |
| 10 years | 0.41 | | 3.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
Bisera Lazarova
BRD | Director/Board Member | - | - |
| Director/Board Member | 63 | 19/05/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/9/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/9/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/9/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.61% | +7.57% | +136.84% | +167.18% | 1.98B | |
| -0.81% | -5.40% | -40.80% | +2.14% | 15.31B | |
| -2.49% | -1.16% | -9.78% | -0.90% | 6.63B | |
| -3.06% | -1.56% | -18.13% | +0.73% | 6.48B | |
| +0.90% | -4.09% | -52.77% | -39.72% | 5.86B | |
| -12.04% | -25.31% | -16.85% | -35.79% | 5.04B | |
| +0.16% | -0.81% | +0.91% | -8.27% | 4.64B | |
| -2.74% | +1.26% | +0.43% | -22.74% | 3.24B | |
| -3.68% | -3.75% | -15.92% | -19.34% | 3.21B | |
| +0.91% | -8.76% | -38.49% | -14.96% | 3.1B | |
| Average | -2.33% | -2.89% | -5.46% | +2.83% | 5.55B | |
| Weighted average by Cap. | -2.20% | -3.13% | -19.73% | -4.89% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.15B 1.06B 966M 1.8B 122B 1.83B 12.77B 5.07B 63.98B 4.82B 4.72B 203B | 2.63B 1.58B 1.42B 1.31B 1.19B 2.22B 150B 2.25B 15.71B 6.24B 78.72B 5.94B 5.81B 250B |
| Net income | 77.85M 46.75M 41.96M 38.75M 35.14M 65.67M 4.44B 66.48M 465M 184M 2.33B 176M 172M 7.38B | 134M 80.19M 71.97M 66.46M 60.26M 113M 7.62B 114M 797M 316M 3.99B 301M 295M 12.66B |
| Net Debt | 444M 267M 239M 221M 200M 375M 25.34B 379M 2.65B 1.05B 13.28B 1B 980M 42.12B | 541M 325M 292M 269M 244M 457M 30.88B 462M 3.23B 1.28B 16.19B 1.22B 1.19B 51.33B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/10/26 | €3.270 | -0.61% | 56,773 |
| 26/10/26 | €3.290 | -0.90% | 30,115 |
| 23/10/26 | €3.320 | +3.75% | 41,241 |
| 22/10/26 | €3.200 | +3.90% | 40,227 |
| 21/10/26 | €3.080 | +1.32% | 5,937 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
